PuSH - Publication Server of Helmholtz Zentrum München

Stem cell-derived vessels-on-chip for cardiovascular disease modeling.

Cell Rep. 43:114008 (2024)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The metabolic syndrome is accompanied by vascular complications. Human in vitro disease models are hence required to better understand vascular dysfunctions and guide clinical therapies. Here, we engineered an open microfluidic vessel-on-chip platform that integrates human pluripotent stem cell-derived endothelial cells (SC-ECs). The open microfluidic design enables seamless integration with state-of-the-art analytical technologies, including single-cell RNA sequencing, proteomics by mass spectrometry, and high-resolution imaging. Beyond previous systems, we report SC-EC maturation by means of barrier formation, arterial toning, and high nitric oxide synthesis levels under gravity-driven flow. Functionally, we corroborate the hallmarks of early-onset atherosclerosis with low sample volumes and cell numbers under flow conditions by determining proteome and secretome changes in SC-ECs stimulated with oxidized low-density lipoprotein and free fatty acids. More broadly, our organ-on-chip platform enables the modeling of patient-specific human endothelial tissue and has the potential to become a general tool for animal-free vascular research.
Impact Factor
Scopus SNIP
Altmetric
7.500
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Cp: Stem Cell Research ; Atherosclerosis ; Disease Modeling ; Hipsc-derived Endothelial Cells ; Open Microfluidics ; Single-cell Sequencing ; Vessel-on-chip; Nitric-oxide Synthase; Shear-stress; Enrichment Analysis; Endothelial-cells; Web Server; Vitronectin; Expression; Generation; Platform
Language english
Publication Year 2024
HGF-reported in Year 2024
ISSN (print) / ISBN 2211-1247
e-ISSN 2211-1247
Journal Cell Reports
Quellenangaben Volume: 43, Issue: 4, Pages: , Article Number: 114008 Supplement: ,
Publisher Cell Press
Publishing Place 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Reviewing status Peer reviewed
Institute(s) Helmholtz Pioneer Campus (HPC)
CF Metabolomics & Proteomics (CF-MPC)
CF Pathology & Tissue Analytics (CF-PTA)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s) 30201 - Metabolic Health
30203 - Molecular Targets and Therapies
30202 - Environmental Health
Research field(s) Pioneer Campus
Enabling and Novel Technologies

Helmholtz Diabetes Center
PSP Element(s) G-510002-001
G-505700-001
A-630600-001
G-555000-001
A-630700-001
Grants ERC Consolidator Grant
EIslet project of the BMBF
Helmholtz Pioneer Campus
Scopus ID 85188672222
PubMed ID 38536819
Erfassungsdatum 2024-05-21